Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI in Pediatric and Neonatal Patient Population (<18years)
The goal of this study is to evaluate safety and efficacy of Dotarem enhanced MRI in pediatric and neonatal population who are referred for contrast enhanced MRI at Phoenix Children's Hospital.
• Any patient under 18 years of age who is scheduled for contrast enhanced MRI examination as part of their standard of care.
• Patients who are willing to undergo contrast enhanced MRI procedure
• Patients who are willing to comply with the study procedures (e.g. being followed-up for 24 hours after MRI procedure).
• Patients who have given their fully informed and written consent voluntarily.